We are scientists, entrepreneurs, and pioneers who are living innovation to deliver more years of life and quality of life for people around the world. Read more about our company, our people and our activities in Our Stories
Judith looks back on our presence at the EBMT 2024 congress, which took place in Glasgow, Scotland. Star Trek, a typical Glaswegian pub and decentralized manufacturing, it’s all in a day’s work. Galapagos was present with a booth, 4 abstracts and 2 oral presentations on our 2 CD19* programs. Read more in Judith’s story.
On this Rare Disease Day, we are honored to share Benita’s courageous journey battling dermatomyositis, a rare autoimmune condition that profoundly impacts her daily life. Dermatomyositis not only affects her skin but also challenges her muscles, turning simple tasks into formidable obstacles.
13 December, 09:00, Schiphol. The wheels of the Delta Airlines flight touch down on the tarmac. 14 hours earlier, we took off at San Diego International Airport. A bit blurry-eyed from the long flight, but with a spring in our stride, we set foot on home soil again after some exciting days at the ASH congress. Read further for our experience at ASH 2023.
On November 15th, our headquarters in Mechelen, Belgium, became a vibrant hub of insightful discussions as we welcomed over 100 participants ranging from over 40 patient organisations and Galapagos employees with the aim of discussing and proposing ways forward for an improved patient engagement relationship.
September marks Blood Cancer Awareness Month, a global initiative dedicated to shedding light on one of the most widespread and dangerous forms of cancer
Read our in-depth interview with Patient Focused Medicines Development (PFMD) about how patient engagement plays a critical role in our Sustainability strategy